Pulse Biosciences (PLSE) Financial Statements & Analysis

Pulse Biosciences (PLSE) Income Statement

Pulse Biosciences reported revenue of $350.00K in fiscal 2025 (fiscal year ended Dec 31, 2025). Pulse Biosciences posted a net loss of $72.78M, compared with a net loss of $53.59M a year earlier. Gross margin was -360.0% and operating margin -21982.6%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $434.00K.

Pulse Biosciences Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Pulse Biosciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Mar 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	0.35	0.00	0.00	0.70	1.42	1.42	0.00	0.00	0.00	0.00
Cost of Revenue	1.61	0.00	1.21	11.94	1.97	1.97	0.67	0.67	0.67	0.67
Gross Profit	-1.26	0.00	-1.21	-11.24	-0.55	-0.55	-0.67	-0.67	-0.67	-0.67
Operating Expenses
Research & Development	44.72	32.34	27.80	20.84	28.64	28.64	26.44	24.96	17.25	9.65
Selling, General & Administrative	32.03	23.92	15.78	25.97	33.82	33.82	22.86	22.33	20.05	15.50
Operating Expenses	75.68	56.26	42.37	46.81	62.46	62.46	48.87	47.95	37.96	25.81
Operating Income	-76.94	-56.26	-43.57	-58.06	-63.01	-63.01	-49.97	-47.95	-37.96	-25.81
Other Income/Expense
Interest Income	4.21	2.67	2.46	0.00	0.00	0.05	0.11	0.98	0.45	0.25
Interest Expense	0.00	0.00	1.10	0.45	0.65	-0.70	0.00	0.00	0.00	0.00
Other Income/Expense	4.16	2.67	1.36	-0.45	-0.65	-0.65	0.11	0.98	0.42	0.25
Income
Income Before Tax	-72.78	-53.59	-42.21	-58.51	-63.66	-63.66	-49.85	-46.97	-37.55	-25.57
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	-0.03	0.00
Net Income	-72.78	-53.59	-42.21	-58.51	-63.66	-63.66	-49.74	-45.99	-37.55	-25.57
Net Income - Continuous Operations	-72.78	-53.59	-42.21	-58.51	-63.66	-63.66	-49.74	-45.99	-37.55	-25.57
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-
EBITDA	-71.71	-52.41	-39.90	-57.15	-62.51	-61.87	-48.87	-46.79	-36.65	-24.57
EBIT	-76.94	-56.26	-43.57	-58.06	-	-63.01	-	-	-	-
Depreciation & Amortization	1.07	1.18	1.21	1.36	1.15	1.15	1.10	1.16	1.31	1.00
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-2.00	-2.00	-2.00	-2.00	-2.00	-2.00	-2.00
Diluted EPS	-1.00	-1.00	-1.00	-2.00	-2.00	-2.00	-2.00	-2.00	-2.00	-2.00
Basic Shares Outstanding	67.40	58.40	48.04	33.94	27.96	28.44	23.25	20.75	17.08	14.75
Diluted Shares Outstanding	67.40	58.40	48.04	33.94	27.96	28.44	23.25	20.75	17.08	14.75

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Pulse Biosciences Financial Statements

What was Pulse Biosciences's revenue in fiscal 2025?

Pulse Biosciences reported revenue of $350.00K in fiscal 2025 (fiscal year ended Dec 31, 2025).

Is Pulse Biosciences profitable?

No. Pulse Biosciences reported a net loss of $72.78M in fiscal 2025. In fiscal 2024 it lost $53.59M.

What is Pulse Biosciences's operating margin?

Pulse Biosciences's operating income was −$76.94M on revenue of $350.00K in fiscal 2025, an operating margin of -21982.6%.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition